KK
Kaken Pharmaceutical Co., Ltd.
KKPCF · OTC
$26.78 +3.00% (+$0.78)
Market Cap ¥153.7B
P/E Ratio 14.98x
Div. Yield 4.77%
ROE 6.91%
Bulios Fair Price
$39.65
48.1% upside
Trenutna cena
$26.78
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica KKPCF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
93 /100
Cheap EV/EBITDA 6.83x
P/S 1.74x
P/B 1.01x
Growth
70 /100
Growing Rev. growth 7.34%
FCF growth 36.06%
Book val. growth 3.48%
Profitability
51 /100
Moderate Net margin 11.62%
Op. margin 11.21%
FCF margin 0.00%
Quality
32 /100
Poor ROE 6.91%
ROA 5.52%
Asset turnover 0.47x
Debt
100 /100
Low Current ratio 4.18x
Int. coverage 223.24x
Net debt/EBITDA -3.65x
Stability
40 /100
Moderate Rev. volatility 19.20%
EPS volatility 60.07%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o KKPCF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Hiroyuki Horiuchi
Employees
1,114
Headquarters
Tokyo
Prihajajoči dogodki
29 SEP.
Ex-Dividend
Ex-dividend date
29 SEP.
Dividend Payment
Datum plačila
05 NOV.
Earnings
Upcoming earnings report
30 MAR.
Ex-Dividend
Ex-dividend date
30 MAR.
Dividend Payment
Datum plačila